Global Irritable Bowel Syndrome Drug Market Growth (Status and Outlook) 2026-2032

September 2026 | 77 pages | ID: GC1B09BCACF4EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Irritable Bowel Syndrome Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Irritable Bowel Syndrome Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Irritable Bowel Syndrome Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Irritable Bowel Syndrome Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Irritable Bowel Syndrome Drug players cover Ironwood Pharmaceuticals, Bausch Health, Takeda, Sebela Pharmaceuticals, Allergan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Irritable Bowel Syndrome Drug Industry Forecast” looks at past sales and reviews total world Irritable Bowel Syndrome Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Irritable Bowel Syndrome Drug sales for 2026 through 2032. With Irritable Bowel Syndrome Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Irritable Bowel Syndrome Drug industry.

This Insight Report provides a comprehensive analysis of the global Irritable Bowel Syndrome Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Irritable Bowel Syndrome Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Irritable Bowel Syndrome Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Irritable Bowel Syndrome Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Irritable Bowel Syndrome Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Irritable Bowel Syndrome Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • IBS-D Drugs
  • IBS-C Drugs
  • Others
Segmentation by Application:
  • Women
  • Men
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Ironwood Pharmaceuticals
  • Bausch Health
  • Takeda
  • Sebela Pharmaceuticals
  • Allergan
1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Irritable Bowel Syndrome Drug Market Size (2021-2032)
  2.1.2 Irritable Bowel Syndrome Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Irritable Bowel Syndrome Drug by Country/Region (2021, 2025 & 2032)
  2.2 Irritable Bowel Syndrome Drug Segment by Type
  2.2.1 IBS-D Drugs
  2.2.2 IBS-C Drugs
  2.2.3 Others
  2.2.4 Irritable Bowel Syndrome Drug Market Size by Type
  2.2.4.1 Irritable Bowel Syndrome Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
  2.2.4.2 Global Irritable Bowel Syndrome Drug Market Size Market Share by Type (2021-2026)
  2.3 Irritable Bowel Syndrome Drug Segment by Application
  2.3.1 Women
  2.3.2 Men
  2.3.3 Irritable Bowel Syndrome Drug Market Size by Application
  2.3.3.1 Irritable Bowel Syndrome Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
  2.3.3.2 Global Irritable Bowel Syndrome Drug Market Size Market Share by Application (2021-2026)

3 IRRITABLE BOWEL SYNDROME DRUG MARKET SIZE BY PLAYER

  3.1 Irritable Bowel Syndrome Drug Market Size Market Share by Player
  3.1.1 Global Irritable Bowel Syndrome Drug Revenue by Player (2021-2026)
  3.1.2 Global Irritable Bowel Syndrome Drug Revenue Market Share by Player (2021-2026)
  3.2 Global Irritable Bowel Syndrome Drug Key Players Head office and Products Offered
  3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.4 New Products and Potential Entrants
  3.5 Mergers & Acquisitions, Expansion

4 IRRITABLE BOWEL SYNDROME DRUG BY REGION

  4.1 Irritable Bowel Syndrome Drug Market Size by Region (2021-2026)
  4.2 Global Irritable Bowel Syndrome Drug Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Irritable Bowel Syndrome Drug Market Size Growth (2021-2026)
  4.4 APAC Irritable Bowel Syndrome Drug Market Size Growth (2021-2026)
  4.5 Europe Irritable Bowel Syndrome Drug Market Size Growth (2021-2026)
  4.6 Middle East & Africa Irritable Bowel Syndrome Drug Market Size Growth (2021-2026)

5 AMERICAS

  5.1 Americas Irritable Bowel Syndrome Drug Market Size by Country (2021-2026)
  5.2 Americas Irritable Bowel Syndrome Drug Market Size by Type (2021-2026)
  5.3 Americas Irritable Bowel Syndrome Drug Market Size by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Irritable Bowel Syndrome Drug Market Size by Region (2021-2026)
  6.2 APAC Irritable Bowel Syndrome Drug Market Size by Type (2021-2026)
  6.3 APAC Irritable Bowel Syndrome Drug Market Size by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia

7 EUROPE

  7.1 Europe Irritable Bowel Syndrome Drug Market Size by Country (2021-2026)
  7.2 Europe Irritable Bowel Syndrome Drug Market Size by Type (2021-2026)
  7.3 Europe Irritable Bowel Syndrome Drug Market Size by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Irritable Bowel Syndrome Drug by Region (2021-2026)
  8.2 Middle East & Africa Irritable Bowel Syndrome Drug Market Size by Type (2021-2026)
  8.3 Middle East & Africa Irritable Bowel Syndrome Drug Market Size by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 GLOBAL IRRITABLE BOWEL SYNDROME DRUG MARKET FORECAST

  10.1 Global Irritable Bowel Syndrome Drug Forecast by Region (2027-2032)
  10.1.1 Global Irritable Bowel Syndrome Drug Forecast by Region (2027-2032)
  10.1.2 Americas Irritable Bowel Syndrome Drug Forecast
  10.1.3 APAC Irritable Bowel Syndrome Drug Forecast
  10.1.4 Europe Irritable Bowel Syndrome Drug Forecast
  10.1.5 Middle East & Africa Irritable Bowel Syndrome Drug Forecast
  10.2 Americas Irritable Bowel Syndrome Drug Forecast by Country (2027-2032)
  10.2.1 United States Market Irritable Bowel Syndrome Drug Forecast
  10.2.2 Canada Market Irritable Bowel Syndrome Drug Forecast
  10.2.3 Mexico Market Irritable Bowel Syndrome Drug Forecast
  10.2.4 Brazil Market Irritable Bowel Syndrome Drug Forecast
  10.3 APAC Irritable Bowel Syndrome Drug Forecast by Region (2027-2032)
  10.3.1 China Irritable Bowel Syndrome Drug Market Forecast
  10.3.2 Japan Market Irritable Bowel Syndrome Drug Forecast
  10.3.3 Korea Market Irritable Bowel Syndrome Drug Forecast
  10.3.4 Southeast Asia Market Irritable Bowel Syndrome Drug Forecast
  10.3.5 India Market Irritable Bowel Syndrome Drug Forecast
  10.3.6 Australia Market Irritable Bowel Syndrome Drug Forecast
  10.4 Europe Irritable Bowel Syndrome Drug Forecast by Country (2027-2032)
  10.4.1 Germany Market Irritable Bowel Syndrome Drug Forecast
  10.4.2 France Market Irritable Bowel Syndrome Drug Forecast
  10.4.3 UK Market Irritable Bowel Syndrome Drug Forecast
  10.4.4 Italy Market Irritable Bowel Syndrome Drug Forecast
  10.4.5 Russia Market Irritable Bowel Syndrome Drug Forecast
  10.5 Middle East & Africa Irritable Bowel Syndrome Drug Forecast by Region (2027-2032)
  10.5.1 Egypt Market Irritable Bowel Syndrome Drug Forecast
  10.5.2 South Africa Market Irritable Bowel Syndrome Drug Forecast
  10.5.3 Israel Market Irritable Bowel Syndrome Drug Forecast
  10.5.4 Turkey Market Irritable Bowel Syndrome Drug Forecast
  10.6 Global Irritable Bowel Syndrome Drug Forecast by Type (2027-2032)
  10.7 Global Irritable Bowel Syndrome Drug Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Irritable Bowel Syndrome Drug Forecast

11 KEY PLAYERS ANALYSIS

  11.1 Ironwood Pharmaceuticals
  11.1.1 Ironwood Pharmaceuticals Company Information
  11.1.2 Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Product Offered
  11.1.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Ironwood Pharmaceuticals Main Business Overview
  11.1.5 Ironwood Pharmaceuticals Latest Developments
  11.2 Bausch Health
  11.2.1 Bausch Health Company Information
  11.2.2 Bausch Health Irritable Bowel Syndrome Drug Product Offered
  11.2.3 Bausch Health Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Bausch Health Main Business Overview
  11.2.5 Bausch Health Latest Developments
  11.3 Takeda
  11.3.1 Takeda Company Information
  11.3.2 Takeda Irritable Bowel Syndrome Drug Product Offered
  11.3.3 Takeda Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Takeda Main Business Overview
  11.3.5 Takeda Latest Developments
  11.4 Sebela Pharmaceuticals
  11.4.1 Sebela Pharmaceuticals Company Information
  11.4.2 Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Product Offered
  11.4.3 Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Sebela Pharmaceuticals Main Business Overview
  11.4.5 Sebela Pharmaceuticals Latest Developments
  11.5 Allergan
  11.5.1 Allergan Company Information
  11.5.2 Allergan Irritable Bowel Syndrome Drug Product Offered
  11.5.3 Allergan Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Allergan Main Business Overview
  11.5.5 Allergan Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Irritable Bowel Syndrome Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Irritable Bowel Syndrome Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of IBS-D Drugs
Table 4. Major Players of IBS-C Drugs
Table 5. Major Players of Others
Table 6. Irritable Bowel Syndrome Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Irritable Bowel Syndrome Drug Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Irritable Bowel Syndrome Drug Market Size Market Share by Type (2021-2026)
Table 9. Irritable Bowel Syndrome Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Irritable Bowel Syndrome Drug Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Irritable Bowel Syndrome Drug Market Size Market Share by Application (2021-2026)
Table 12. Global Irritable Bowel Syndrome Drug Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Irritable Bowel Syndrome Drug Revenue Market Share by Player (2021-2026)
Table 14. Irritable Bowel Syndrome Drug Key Players Head office and Products Offered
Table 15. Irritable Bowel Syndrome Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Irritable Bowel Syndrome Drug Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Irritable Bowel Syndrome Drug Market Size Market Share by Region (2021-2026)
Table 20. Global Irritable Bowel Syndrome Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Irritable Bowel Syndrome Drug Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Irritable Bowel Syndrome Drug Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Irritable Bowel Syndrome Drug Market Size Market Share by Country (2021-2026)
Table 24. Americas Irritable Bowel Syndrome Drug Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Irritable Bowel Syndrome Drug Market Size Market Share by Type (2021-2026)
Table 26. Americas Irritable Bowel Syndrome Drug Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Irritable Bowel Syndrome Drug Market Size Market Share by Application (2021-2026)
Table 28. APAC Irritable Bowel Syndrome Drug Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Irritable Bowel Syndrome Drug Market Size Market Share by Region (2021-2026)
Table 30. APAC Irritable Bowel Syndrome Drug Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Irritable Bowel Syndrome Drug Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Irritable Bowel Syndrome Drug Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Irritable Bowel Syndrome Drug Market Size Market Share by Country (2021-2026)
Table 34. Europe Irritable Bowel Syndrome Drug Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Irritable Bowel Syndrome Drug Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Irritable Bowel Syndrome Drug Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Irritable Bowel Syndrome Drug Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Irritable Bowel Syndrome Drug Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Irritable Bowel Syndrome Drug
Table 40. Key Market Challenges & Risks of Irritable Bowel Syndrome Drug
Table 41. Key Industry Trends of Irritable Bowel Syndrome Drug
Table 42. Global Irritable Bowel Syndrome Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Irritable Bowel Syndrome Drug Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Irritable Bowel Syndrome Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Irritable Bowel Syndrome Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Ironwood Pharmaceuticals Details, Company Type, Irritable Bowel Syndrome Drug Area Served and Its Competitors
Table 47. Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Product Offered
Table 48. Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Ironwood Pharmaceuticals Main Business
Table 50. Ironwood Pharmaceuticals Latest Developments
Table 51. Bausch Health Details, Company Type, Irritable Bowel Syndrome Drug Area Served and Its Competitors
Table 52. Bausch Health Irritable Bowel Syndrome Drug Product Offered
Table 53. Bausch Health Irritable Bowel Syndrome Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Bausch Health Main Business
Table 55. Bausch Health Latest Developments
Table 56. Takeda Details, Company Type, Irritable Bowel Syndrome Drug Area Served and Its Competitors
Table 57. Takeda Irritable Bowel Syndrome Drug Product Offered
Table 58. Takeda Irritable Bowel Syndrome Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Takeda Main Business
Table 60. Takeda Latest Developments
Table 61. Sebela Pharmaceuticals Details, Company Type, Irritable Bowel Syndrome Drug Area Served and Its Competitors
Table 62. Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Product Offered
Table 63. Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Sebela Pharmaceuticals Main Business
Table 65. Sebela Pharmaceuticals Latest Developments
Table 66. Allergan Details, Company Type, Irritable Bowel Syndrome Drug Area Served and Its Competitors
Table 67. Allergan Irritable Bowel Syndrome Drug Product Offered
Table 68. Allergan Irritable Bowel Syndrome Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Allergan Main Business
Table 70. Allergan Latest Developments

LIST OF FIGURES

Figure 1. Irritable Bowel Syndrome Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Irritable Bowel Syndrome Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Irritable Bowel Syndrome Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Irritable Bowel Syndrome Drug Sales Market Share by Country/Region (2025)
Figure 8. Irritable Bowel Syndrome Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Irritable Bowel Syndrome Drug Market Size Market Share by Type in 2025
Figure 10. Irritable Bowel Syndrome Drug in Women
Figure 11. Global Irritable Bowel Syndrome Drug Market: Women (2021-2026) & ($ millions)
Figure 12. Irritable Bowel Syndrome Drug in Men
Figure 13. Global Irritable Bowel Syndrome Drug Market: Men (2021-2026) & ($ millions)
Figure 14. Global Irritable Bowel Syndrome Drug Market Size Market Share by Application in 2025
Figure 15. Global Irritable Bowel Syndrome Drug Revenue Market Share by Player in 2025
Figure 16. Global Irritable Bowel Syndrome Drug Market Size Market Share by Region (2021-2026)
Figure 17. Americas Irritable Bowel Syndrome Drug Market Size 2021-2026 ($ millions)
Figure 18. APAC Irritable Bowel Syndrome Drug Market Size 2021-2026 ($ millions)
Figure 19. Europe Irritable Bowel Syndrome Drug Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Irritable Bowel Syndrome Drug Market Size 2021-2026 ($ millions)
Figure 21. Americas Irritable Bowel Syndrome Drug Value Market Share by Country in 2025
Figure 22. United States Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Irritable Bowel Syndrome Drug Market Size Market Share by Region in 2025
Figure 27. APAC Irritable Bowel Syndrome Drug Market Size Market Share by Type (2021-2026)
Figure 28. APAC Irritable Bowel Syndrome Drug Market Size Market Share by Application (2021-2026)
Figure 29. China Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. India Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Irritable Bowel Syndrome Drug Market Size Market Share by Country in 2025
Figure 36. Europe Irritable Bowel Syndrome Drug Market Size Market Share by Type (2021-2026)
Figure 37. Europe Irritable Bowel Syndrome Drug Market Size Market Share by Application (2021-2026)
Figure 38. Germany Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 39. France Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Irritable Bowel Syndrome Drug Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Irritable Bowel Syndrome Drug Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Irritable Bowel Syndrome Drug Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Irritable Bowel Syndrome Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 52. APAC Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 53. Europe Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 55. United States Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 56. Canada Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 57. Mexico Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 58. Brazil Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 59. China Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 60. Japan Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 61. Korea Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 63. India Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 64. Australia Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 65. Germany Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 66. France Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 67. UK Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 68. Italy Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 69. Russia Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 70. Egypt Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 71. South Africa Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 72. Israel Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 73. Turkey Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)
Figure 74. Global Irritable Bowel Syndrome Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Irritable Bowel Syndrome Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Irritable Bowel Syndrome Drug Market Size 2027-2032 ($ millions)


More Publications